Department of Justice (DOJ), which reported the inappropriate use of these devices. This affected the
sales of CRM devices.
The defibrillators and pacemakers markets showed flat growth rates in the U.S. from 2009 to 2011.
However with technological advancements such as introduction of MRI pacemakers, subcutaneous ICDs,
and home automated external defibrillators (AEDs), this market is expected to bounce back.
North America is the largest market for cardiac monitoring and cardiac rhythm management, with the U.S.
accounting for the largest share, followed by Europe and Asia. North America and Europe is expected to
grow at a slower pace, primarily due to the economic slowdown and market maturity. The Asian market,
especially India and China, is expected to witness a boost in demand and is poised to register maximum
growth over the next five years, owing to the rising incidence of cardiovascular diseases and increased
purchasing power of patients.
The key players in the cardiac monitoring and cardiac rhythm management market are Boston Scientific
(U.S.),Cardiac Science Corporation (U.S.), CardioNet (U.S.), GE Healthcare (U.K.), LifeWatch
(Switzerland), Medtronic (U.S.), Mortara Instruments (U.S.), Philips Healthcare (The Netherlands),
Schiller (Switzerland), Spacelabs Healthcare (U.S.), St. Jude Medical (U.S.), Welch Allyn (U.S.), and Zoll
Medical Corporation (U.S.).
About MarketsandMarkets:
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish
strategically analyzed market research reports and serve as a business intelligence partner to Fortune
500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research
services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive
and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semi